New UK Treatment Strategy Reduce Risk of Bowel Cancer by 28%
According to the findings of a trial, chemotherapy given to patients with bowel cancer prior to surgery reduces the risk of the cancer returning by 28%. One in three people who are diagnosed with the disease experience a recurrence after surgery, a number that has been called “far too high” by cancer specialists who have […]
Continue Reading